In the last trading session, 12.41 million Geron Corp (NASDAQ:GERN) shares changed hands as the company’s beta touched 0.57. With the company’s per share price at $2.94 changed hands at -$0.04 or -1.34% during last session, the market valuation stood at $1.78B. GERN’s last price was a discount, traded about -81.63% off its 52-week high of $5.34. The share price had its 52-week low at $1.64, which suggests the last value was 44.22% up since then. When we look at Geron Corp’s average trading volume, we note the 10-day average is 17.45 million shares, with the 3-month average coming to 10.43 million.
Analysts gave the Geron Corp (GERN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.11. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended GERN as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Geron Corp (NASDAQ:GERN) trade information
Instantly GERN was in red as seen at the end of in last trading. With action -14.29%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -16.95%, with the 5-day performance at -14.29% in the red. However, in the 30-day time frame, Geron Corp (NASDAQ:GERN) is -26.13% down. Looking at the short shares, we see there were 65.07 million shares sold at short interest cover period of 5.7 days.
The consensus price target for the stock as assigned by Wall Street analysts is 7, meaning bulls need an upside of 58.0% from its current market value. According to analyst projections, GERN’s forecast low is 5.5 with 8 as the target high. To hit the forecast high, the stock’s price needs a -172.11% plunge from its current level, while the stock would need to soar -87.07% for it to hit the projected low.
Geron Corp (GERN) estimates and forecasts
Data shows that the Geron Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -40.00% over the past 6 months, a 18.75% in annual growth rate that is considerably higher than the industry average of 16.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.08%. The 2025 estimates are for Geron Corp earnings to increase by 19.11%.
GERN Dividends
Geron Corp is expected to release its next quarterly earnings report in February.
Geron Corp (NASDAQ:GERN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.09% of Geron Corp shares while 85.40% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 85.48%. There are 85.40% institutions holding the Geron Corp stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 7.7138% of the shares, roughly 46.55 million GERN shares worth $197.38 million.
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 7.6558% or 46.2 million shares worth $195.9 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF . With 17.84 shares estimated at $52.45 million under it, the former controlled 2.95% of total outstanding shares. On the other hand, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF held about 2.53% of the shares, roughly 15.31 shares worth around $45.01 million.
